Budczies, Jan

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment

Breast Cancer Treatment StudiesGene expression and cancer classification

Cited by 4,169

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Denkert, C., von Minckwitz, G., Darb-Esfahani, S., Lederer, B., Heppner, B. I., Weber, K. E., Budczies, J., Huober, J., Klauschen, F., Furlanetto, J., et al. (2018) · The Lancet Oncology

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 2,157

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

Sha, D., Jin, Z., Budczies, J., Kluck, K., Stenzinger, A., & Sinicrope, F. A. (2020) · Cancer Discovery

Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Cited by 859

Subgroup-specific immune and stromal microenvironment in medulloblastoma

Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U. (2018) · OncoImmunology

Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 121

Structure and content of the EU-IVDR: Current status and implications for pathology

Kahles, A., Goldschmid, H., Volckmar, A.-L., Ploeger, C., Kazdal, D., Penzel, R., Budczies, J., Kempny, G., Kazmierczak, M., Flechtenmacher, C., et al. (2023) · Die Pathologie

Healthcare RegulationClinical Laboratory Practices and Quality Control

Cited by 27